Effect of losartan pretreatment on kidney lipid content after unilateral obstruction in rats

Cellular and Molecular Biology

Volumn 51, Issue 6, 2005, Pages 539-545

  Manucha, W ^a   Carrizo, L ^a   Alvarez, S ^b   Valles P ^a   Oliveros, L ^b  

^a Centro Universitario   (Argentina)

^b UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

Author keywords

Angiotensin II AT1 receptor; Cholesterol; Losartan; Phospholipids; Renal cortex; Unilateral ureteral obstruction

Indexed keywords

ACETIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CARBON 14; CHOLESTEROL ESTER; CHOLINE; DRINKING WATER; LIPID; LOSARTAN; MESSENGER RNA; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; SPHINGOMYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL LABELING; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; KIDNEY CORTEX; LIPID COMPOSITION; NONHUMAN; RAT; URETER OBSTRUCTION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CHOLESTEROL; FATTY ACIDS; FEMALE; GENE EXPRESSION REGULATION; KIDNEY CORTEX; LIPID METABOLISM; LIPIDS; LOSARTAN; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; RATS; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SPHINGOMYELINS; URETERAL OBSTRUCTION;

ANIMALIA;

EID: 28144463395     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T661     Document Type: Article

References (27)

1. Abell, L.L., Levy, B.B., Brodie, B.B. and Kendall, F.E., A simplied method for the estimation of total cholesterol in serum and demonstration of its specificity. J. Biol. Chem. 1952, 195: 357-366.
2. Brown, M.S. and Goldstein, J.L., A receptor-mediated pathway for the cholesterol homeostasis. Science Wash DC 1984, 232: 34-47.
3. Dahr, S.S., Gee, J., Dipp, S., Hanss, B.G., Vari, R.C. and Chao, J., Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropaty. Am. J. Physiol. 1993, 264: F874-F881.
4. Erickson, S.K., Shrewsbury, M.A., Brooks, C. and Meyer, D.L., Rat liver acyl-coenzyme A: cholesterol acyltransferase: Its egulation in vivo and some of its properties in vitro. J. Lipid Res. 1980, 21: 930-941.
5. Folch, J., Less, M. and Sloane-Stanley, G.H., A simple method for the isolation and purification of total lipid from animal tissues. J. Biol. Chem. 1968, 226: 497-509.
6. Gironacci, M.M., Fernandez-Tome, M. del C., Speziale, E., Sterin-Spezial, N. and Pena, N., Enhancement of phosphatidylcholine biosynthesis by angiotensin-(1-7) in the rat renal cortex. Biochem. Pharmacol. 2002, 63: 507-514.
7. Harrison-Bernard, L.M., El-Dahr, S., O'Leary, D.F. and Navar, L.G., Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension 1999, 33: 340-346.
8. Henneberry, A.L., Wright, M.M. and McMaster, C.R., The major sites of cellular phospholipid synthesis and molecular determinants of fatty acid and lipid head group specificity. Mol. Biol. Cell 2002, 13: 3148-3161.
9. Kaneto, H., Morrissey, J., McCracken, R., Ishidoya, S., Reyes, A. and Klahr, S., The expression of mRNA for tumor necrosis factor β increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrology 1996, 2: 161-166.
10. Kaplan, M., Aviram, M., Knopf, C. and Keidar, S., Angiotensin II reduces macrophage cholesterol efflux: Arole for the AT-1 receptor but not for the ABC1 transporter. Biochem. Biophys. Res. Commun. 2002, 290: 1529-1534.
11. Kerkhoff, C., Beuck, M., Threige-Rasmussen, J., Spener, F., Knudsen, J. and Schmitz, G., Acyl-CoA binding protein (ACBP) regulates acyl-CoA:cholesterol acyltransferase (ACAT) in human mononuclear phagocytes. Biochim. Biophys. Acta 1997, 1346: 163-172.
12. Klahr, S., Harris, K. and Purkerson, M.L., Effects of obstruction on renal functions. Pediatr. Nephrol. 1998, 2: 34-42.
13. Manucha, W., Oliveros, L., Carrizo, L., Seltzer, A. and Vallés, P., Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney Int. 2004, 65: 1-17.
14. Ohvo-Rekila, H., Ramstedt, B., Leppimaki, P. and Slotte, J.P., Cholesterol interactions with phospholipids in membranes. Progress Lipid Res. 2000, 41: 66-97.
15. Parekh, D.B., Ziegler, W. and Parker P.J., Multiple pathways control protein kinase C phosphorylation. EMBO J. 2000, 19: 496-503.
16. Qin, J.Z, Liu, J., Sun, L., Hu, L., Cooper, M.E. and Cao, Z., Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes. Kidney Int. 2003, 64: 565-571.
17. Rauser, G., Fluster, S. and Yamamoto, A., Two dimensional thin-layer chromatographic separation of polar lipid and determination of phospholipid analysis of spots. Lipids 1970, 5: 494-496.
18. 1 receptor-independent function of losartan. Circ. Res. 2002, 90: 754-756.
19. Schneiter, R., Brugger, B., Sandhoff, R., Zellnig, G., Leber, A., Lampl, M., Athenstaedt, K., Hrastnik, C., Eder, S., Daum, G., Paltauf, F., Wieland, F.T. and Kohlwein, S.D., Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species in route to the plasma membrane. J. Cell. Biol. 1999, 146: 741-754.
20. Shiratori, I., Okwu, A.K. and Tabas, I., Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and upregulation of CTP-phosphatidylcholine cytidylyltransferase. J. Biol. Chem. 1994, 269: 11337-11348.
21. Vallés, P., Merlo, V., Berón, W. and Manucha, W., Recovery of distal nephron enzyme activity after release of unilateral ureteral obstruction. J. Urol. 1999, 161: 641-648.
22. Wyse, B.D., Prior. I.A., Qian. H., Morrow, I.C., Nixon, S., Muncke, C., Kurzchalia, T.V., Thomas, W.G., Parton, R.G. and Hancock, J.F., Caveolin interacts with the angiotensin II type receptor during exocytic transport but not at the plasma membrane. J. Biol. Chem. 2003, 278: 23738-23746.
23. 2 receptors in neonatal ureteral obstruction. Am. J. Physiol. (Regul. Integr. Comp. Physiol.) 1997, 273: R503-R509.
24. Zack, B., Moss, N., Boyle, A.S. and Zlatkis, A., Reactions of certain unsaturated steroids with acid iron reagent. Anal. Chem. 1954, 26: 776-777.
25. Zager, R.A., Burkhart, K.M., Johnson, A.C.M. and Sacks, B.M., Increased proximal tubular cholesterol content: Implications for cell injury and acquired cytoresistance. Kidney Int. 1999, 56: 1788-1797.
26. Zager, R.A., Plasma membrane cholesterol: Acritical determinant of cellular energetics and tubular resistance to attack. Kidney Int. 2000, 58: 193-205.
27. Zager, R.A., Johnson, A., Hanson, S. and De la Rosa, V., Altered cholesterol localization and caveolin expression during the evolution of acute renal failure. Kidney Int. 2002, 61: 1674-1683.